VACCINE TO TREAT COVID-19 STILL 12 MONTHS AWAY???

35 drugs in the race to treat new coronavirus

Big pharma companies like GlaxoSmithKline and Sanofi to small biotechs such as Moderna and Gilead Sciences are in the race but the researchers worldwide feel a vaccine to treat COVID-19 is at least 12 month away.

The world is scrambling to find a vaccine to treat the new coronavirus (COVID-19) as new cases keep emerging, a survey by Genetic Engineering & Biotechnology News (GEN) has revealed that 35 active drug development programmes are currently on in North America, Europe and China.

Big pharma companies like GlaxoSmithKline and Sanofi to small biotechs such as Moderna and Gilead Sciences are in the race but the researchers worldwide feel a vaccine to treat COVID-19 is at least 12 month away.

Gilead has already begun clinical trials in China after peer-reviewed journals showed that its antiviral candidate, remdesivir, had positive results in a case involving a US patient and Chinese in vitro tests.

Synergizing healthcare breakthroughs from around the world

Global bio-pharmaceutical company Takeda said this week it has initiated development of a plasma-derived therapy for new coronavirus (COVID-19) and produce the therapy termed as “TAK-888”.

Hyper immune globulins are plasma derived-therapies that have previously been shown to be effective in the treatment of severe acute viral respiratory infections and may be a treatment option for COVID-19.